Cytoreduction and Stem Cell Mobilization With Rituximab and ICE for Patients With Refractory or Relapsed CD20+ B-Cell IGL Eligible for ASCT: The RICE Protocol
Phase of Trial: Phase II
Latest Information Update: 03 Feb 2010
At a glance
- Drugs Rituximab (Primary) ; Carboplatin; Etoposide; Filgrastim; Ifosfamide
- Indications Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 17 Dec 2009 Actual end date (Nov 2002) added as reported by ClinicalTrials.gov.
- 10 Sep 2005 New trial record.